These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 38914679)
1. A genomic instability-associated lncRNA signature for predicting prognosis and biomarkers in lung adenocarcinoma. Lin C; Lin K; Li P; Yuan H; Lin X; Dai Y; Zhang Y; Xie Z; Liu T; Wei C Sci Rep; 2024 Jun; 14(1):14460. PubMed ID: 38914679 [TBL] [Abstract][Full Text] [Related]
2. A methylation-related lncRNA-based prediction model in lung adenocarcinomas. Yang K; Liu H; Li JH Clin Respir J; 2024 Aug; 18(8):e13753. PubMed ID: 39187946 [TBL] [Abstract][Full Text] [Related]
3. A novel autophagy-related lncRNA survival model for lung adenocarcinoma. Wu L; Wen Z; Song Y; Wang L J Cell Mol Med; 2021 Jun; 25(12):5681-5690. PubMed ID: 33987935 [TBL] [Abstract][Full Text] [Related]
4. Disulfidptosis-related lncRNAs signature predicting prognosis and immunotherapy effect in lung adenocarcinoma. Hong S; Zhang Y; Wang D; Wang H; Zhang H; Jiang J; Chen L Aging (Albany NY); 2024 Jun; 16(11):9972-9989. PubMed ID: 38862217 [TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of lung adenocarcinoma: A potential four-long noncoding RNA prognostic signature. Sui J; Yang S; Liu T; Wu W; Xu S; Yin L; Pu Y; Zhang X; Zhang Y; Shen B; Liang G J Cell Biochem; 2019 Jan; 120(1):705-714. PubMed ID: 30125988 [TBL] [Abstract][Full Text] [Related]
6. Mutation-Derived Long Noncoding RNA Signature Predicts Survival in Lung Adenocarcinoma. Yang L; Guo G; Yu X; Wen Y; Lin Y; Zhang R; Zhao D; Huang Z; Wang G; Yan Y; Zhang X; Chen D; Xing W; Wang W; Zeng W; Zhang L Front Oncol; 2022; 12():780631. PubMed ID: 35372012 [TBL] [Abstract][Full Text] [Related]
7. Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma. Zhang X; Han J; Du L; Li X; Hao J; Wang L; Zheng G; Duan W; Xie Y; Zhao Y; Zhang X; Zou M; Wang C Thorac Cancer; 2020 Mar; 11(3):728-737. PubMed ID: 31994347 [TBL] [Abstract][Full Text] [Related]
8. Characterization of an endoplasmic reticulum stress-associated lncRNA prognostic signature and the tumor-suppressive role of RP11-295G20.2 knockdown in lung adenocarcinoma. Yu L; Zhou S; Hong W; Lin N; Wang Q; Liang P Sci Rep; 2024 May; 14(1):12283. PubMed ID: 38811828 [TBL] [Abstract][Full Text] [Related]
9. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma. Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618 [TBL] [Abstract][Full Text] [Related]
10. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma. Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804 [TBL] [Abstract][Full Text] [Related]
11. Identification and validation of a novel redox-related lncRNA prognostic signature in lung adenocarcinoma. Ren J; Wang A; Liu J; Yuan Q Bioengineered; 2021 Dec; 12(1):4331-4348. PubMed ID: 34338158 [TBL] [Abstract][Full Text] [Related]
12. Prediction of bladder cancer outcome by identifying and validating a mutation-derived genomic instability-associated long noncoding RNA (lncRNA) signature. Wu H; Zhang ZY; Zhang Z; Xiao XY; Gao SL; Lu C; Zuo L; Zhang LF Bioengineered; 2021 Dec; 12(1):1725-1738. PubMed ID: 33955803 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma. Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085 [No Abstract] [Full Text] [Related]
14. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models. Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990 [TBL] [Abstract][Full Text] [Related]
15. Identification of 4 immune cells and a 5-lncRNA risk signature with prognosis for early-stage lung adenocarcinoma. Mu L; Ding K; Tu R; Yang W J Transl Med; 2021 Mar; 19(1):127. PubMed ID: 33771173 [TBL] [Abstract][Full Text] [Related]
16. Identification of a RNA-Seq Based Prognostic Signature with Seven Immune-Related lncRNAs for Lung Adenocarcinoma. You J; Fang W; Zhao Q; Chen L; Chen L; Chen F Clin Lab; 2021 Mar; 67(3):. PubMed ID: 33739047 [TBL] [Abstract][Full Text] [Related]
17. Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers. Li R; Yang YE; Yin YH; Zhang MY; Li H; Qu YQ J Transl Med; 2019 Sep; 17(1):324. PubMed ID: 31558162 [TBL] [Abstract][Full Text] [Related]
18. Identification of a methyltransferase-related long noncoding RNA signature as a novel prognosis biomarker for lung adenocarcinoma. Sun YY; Li S; Liu C; Pan Y; Xiao Y Aging (Albany NY); 2024 May; 16(10):8747-8771. PubMed ID: 38771129 [TBL] [Abstract][Full Text] [Related]
19. Immune-related eight-lncRNA signature for improving prognosis prediction of lung adenocarcinoma. Chen Y; Zhang X; Li J; Zhou M J Clin Lab Anal; 2021 Nov; 35(11):e24018. PubMed ID: 34550610 [TBL] [Abstract][Full Text] [Related]
20. A seven-long noncoding RNA signature predicts relapse in patients with early-stage lung adenocarcinoma. Zhou H; Zhang H; Chen J; Cao J; Liu L; Guo C; Huang G; Zeng D J Cell Biochem; 2019 Sep; 120(9):15730-15739. PubMed ID: 31050375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]